Precision Medicine Advances in Early Breast Cancer: Experts Discuss the Expanding Role of Biomarkers to Guide Neo/Adjuvant Therapy

Goal:,The goal of this activity is to improve the knowledge, confidence, and competence of learners caring for patients with early-stage breast cancer.,Learning Objectives:,• Appraise current/emerging published data and consensus-based guidelines to inform the use of biomarkers and genomic classifiers to assess risk of recurrence,• Plan optimal neoadjuvant/adjuvant treatment strategies with approved targeted or immunotherapy agents for appropriate patients with EBC,• Develop strategies to anticipate, monitor, and manage adverse events with current and emerging therapies for HR+/HER2- EBC to improve adherence and optimize outcomes,• Identify patients with HR+/HER2- EBC eligible for enrollment on ongoing clinical studies investigating novel therapies,Additional details will be posted as soon as information is available.